Company / Cash per Share
Lilly (Eli) Cash per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$8.05
FY2025
5-year range
$2.27 / $8.05
FY2021-FY2025
Trend
+122.7%
vs FY2024
Sector context
#25 of 205
Health Care
What the data says
Lilly (Eli)'s cash per share of $8.05 is higher than 88% of companies in the Health Care sector (FY2025). Cash per Share has increased for 3 consecutive years, from $2.27 in FY2022 to $8.05 in FY2025.
Based on SEC 10-K filings.
8.05 in FY2025 with a 5-year CAGR of +17.9%. Top quartile in the Health Care sector.
Improved from $3.09 to $8.05 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- +52.6%
- 5-Year CAGR
- +17.9%
- 10-Year CAGR
- -
Sector benchmark
Top 12% in Health CareTop 12% of 205This company $8.05 Sector average $67.98
▼
-88.2% below sector average
Key checks
Key Insights
- Lilly (Eli)'s cash per share has grown for 3 consecutive years.
- In FY2025, cash per share increased 122.7% year-over-year.
- Ranks #25 out of 205 companies in the Health Care sector.
- Lowest cash per share in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 1.02 (distress zone, below 1.8 threshold)
- Strong profit margin: 31.0%
- Low earnings quality (accrual-heavy earnings)
- Strong return on equity: 77.4%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $8.05 | +122.7% |
| FY2024 | $3.61 | +16.8% |
| FY2023 | $3.09 | +36.5% |
| FY2022 | $2.27 | -44.5% |
| FY2021 | $4.08 | +15.3% |
| FY2020 | $3.54 | +59.2% |
| FY2019 | $2.22 | -67.8% |
| FY2018 | $6.89 | +100.4% |
| FY2017 | $3.44 | -19.3% |
| FY2016 | $4.27 | +26.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026